+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5012999
  • Report
  • June 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Real World Evidence Solution Market will Grow to USD 1,785.13 Million by 2025, at a CAGR of 13.16%

FEATURED COMPANIES

  • Certara, L.P.
  • HealthiVibe, LLC
  • ICON PLC
  • Mercy Technology Services
  • SAS Institute, Inc.
  • Syneos Health
  • MORE
The Global Real World Evidence Solution Market size was estimated at USD 849.87 Million in 2019 and expected to reach USD 954.90 Million in 2020, at a Compound Annual Growth Rate (CAGR) 13.16% to reach USD 1,785.13 Million by 2025.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2017 and 2018 are considered historical years, 2019 as the base year, 2020 as the estimated year, and years from 2021 to 2025 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Real World Evidence Solution to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the Real World Evidence Solution Market was studied across Data Set and Services. The Data Set is further studied across Claims Data, Clinical Settings Data, Patient-Powered Data, and Pharmacy Data.
  • Based on End-User, the Real World Evidence Solution Market was studied across Biopharmaceutical Company, Clinical & Life Sciences Organization, and Diagnostics or Medical Device Company.
  • Based on Therapeutic Area, the Real World Evidence Solution Market was studied across Cardiovascular, Immunology, Infectious Diseases, Neurology, and Oncology.
  • Based on Region, the Real World Evidence Solution Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Real World Evidence Solution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Real World Evidence Solution Market, including Certara, L.P., Clinigen Group PLC, Cognizant Technology Solutions Corp., HealthiVibe, LLC, IBM Corporation, ICON PLC, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute, Inc., Sciformix Corporation, Syneos Health, and Turacoz.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Real World Evidence Solution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Real World Evidence Solution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Real World Evidence Solution Market?
4. What is the competitive strategic window for opportunities in the Global Real World Evidence Solution Market?
5. What are the technology trends and regulatory frameworks in the Global Real World Evidence Solution Market?
6. What is the market share of the leading vendors in the Global Real World Evidence Solution Market?
7. What modes and strategic moves are considered suitable for entering the Global Real World Evidence Solution Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Certara, L.P.
  • HealthiVibe, LLC
  • ICON PLC
  • Mercy Technology Services
  • SAS Institute, Inc.
  • Syneos Health
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. End-User Outlook
3.5. Therapeutic Area Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Shift from volume to value based care
5.1.1.2. Delays in drug development and the subsequent increase in development costs
5.1.1.3. Drug safety and effectiveness after clinical trials
5.1.2. Restraints
5.1.2.1. Reluctance to rely on real-world studies
5.1.3. Opportunities
5.1.3.1. Rising focus on end-to-end RWE services
5.1.3.2. Emerging roles of wearable devices and AI in RWE
5.1.4. Challenges
5.1.4.1. Lack of universally accepted methodological standards and data processing infrastructure
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Real World Evidence Solution Market, by Component
6.1. Introduction
6.2. Data Set
6.2.1. Claims Data
6.2.2. Clinical Settings Data
6.2.3. Patient-Powered Data
6.2.4. Pharmacy Data
6.3. Services

7. Real World Evidence Solution Market, by End-User
7.1. Introduction
7.2. Biopharmaceutical Company
7.3. Clinical & Life Sciences Organization
7.4. Diagnostics or Medical Device Company

8. Real World Evidence Solution Market, by Therapeutic Area
8.1. Introduction
8.2. Cardiovascular
8.3. Immunology
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology

9. Americas Real World Evidence Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Real World Evidence Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Real World Evidence Solution Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Quadrant
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Certara, L.P.
13.2. Clinigen Group PLC
13.3. Cognizant Technology Solutions Corp.
13.4. HealthiVibe, LLC
13.5. IBM Corporation
13.6. ICON PLC
13.7. IQVIA
13.8. Mercy Technology Services
13.9. Oracle Corporation
13.10. PAREXEL International Corporation
13.11. Pharmaceutical Product Development, LLC
13.12. SAS Institute, Inc.
13.13. Sciformix Corporation
13.14. Syneos Health
13.15. Turacoz

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 (USD MILLION)
FIGURE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 (USD MILLION)
FIGURE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 (USD MILLION)
FIGURE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY REGION, 2019 (USD MILLION)
FIGURE 6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (%)
FIGURE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2025
FIGURE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2017-2025 (USD MILLION)
FIGURE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, 2017-2025 (USD MILLION)
FIGURE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, 2017-2025 (USD MILLION)
FIGURE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, 2017-2025 (USD MILLION)
FIGURE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, 2017-2025 (USD MILLION)
FIGURE 21. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, 2017-2025 (USD MILLION)
FIGURE 23. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (%)
FIGURE 25. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2025
FIGURE 27. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, 2017-2025 (USD MILLION)
FIGURE 28. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, 2017-2025 (USD MILLION)
FIGURE 30. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, 2017-2025 (USD MILLION)
FIGURE 32. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (%)
FIGURE 34. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2025
FIGURE 36. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, 2017-2025 (USD MILLION)
FIGURE 37. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, 2017-2025 (USD MILLION)
FIGURE 39. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2025 (USD MILLION)
FIGURE 41. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, 2017-2025 (USD MILLION)
FIGURE 43. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, 2017-2025 (USD MILLION)
FIGURE 45. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2019 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 47. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 48. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 49. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 50. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 51. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 52. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 53. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 54. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 55. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 56. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 57. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 58. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 59. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 60. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 61. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 63. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 64. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 65. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 66. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 67. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 68. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 71. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 74. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY QUADRANT, 2019
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY REGION, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY REGION, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY REGION, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY REGION, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY REGION, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 22. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 23. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 24. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 25. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 26. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 27. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 28. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 29. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 30. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 31. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 32. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 33. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 34. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 35. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 36. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 38. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 39. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 40. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 41. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 42. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 43. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 44. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 45. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 46. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 47. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 48. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 49. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SCORES
TABLE 50. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RANKING
TABLE 53. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SHARE, BY QUADRANT, 2019
TABLE 54. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Certara, L.P.
  • Clinigen Group PLC
  • Cognizant Technology Solutions Corp.
  • HealthiVibe, LLC
  • IBM Corporation
  • ICON PLC
  • IQVIA
  • Mercy Technology Services
  • Oracle Corporation
  • PAREXEL International Corporation
  • Pharmaceutical Product Development, LLC
  • SAS Institute, Inc.
  • Sciformix Corporation
  • Syneos Health
  • Turacoz
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll